BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 10222130)

  • 21. The ubiquitin-proteasome proteolytic pathway.
    Ciechanover A
    Cell; 1994 Oct; 79(1):13-21. PubMed ID: 7923371
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanisms activated by kidney disease and the loss of muscle mass.
    Mitch WE; Price SR
    Am J Kidney Dis; 2001 Dec; 38(6):1337-42. PubMed ID: 11728972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutamine starvation of monocytes inhibits the ubiquitin-proteasome proteolytic pathway.
    Zellner M; Gerner C; Munk Eliasen M; Wurm S; Pollheimer J; Spittler A; Brostjan C; Roth E; Oehler R
    Biochim Biophys Acta; 2003 Jul; 1638(2):138-48. PubMed ID: 12853119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms stimulating protein degradation to cause muscle atrophy.
    Price SR; Mitch WE
    Curr Opin Clin Nutr Metab Care; 1998 Jan; 1(1):79-83. PubMed ID: 10565334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of oxidant systems on the ubiquitylation of proteins in the central nervous system.
    Adamo AM; Pasquini LA; Moreno MB; Oteiza PI; Soto EF; Pasquini JM
    J Neurosci Res; 1999 Feb; 55(4):523-31. PubMed ID: 10723062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms causing loss of muscle in acute uremia.
    Mitch WE
    Ren Fail; 1996 May; 18(3):389-94. PubMed ID: 8827983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 tat inhibits the 20 S proteasome and its 11 S regulator-mediated activation.
    Seeger M; Ferrell K; Frank R; Dubiel W
    J Biol Chem; 1997 Mar; 272(13):8145-8. PubMed ID: 9079628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of the ubiquitin-conjugating and proteolytic systems in murine acquired immunodeficiency syndrome.
    Crinelli R; Fraternale A; Casabianca A; Magnani M
    Eur J Biochem; 1997 Jul; 247(1):91-7. PubMed ID: 9249013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New rule proposed for protein degradation.
    Kolata G
    Science; 1986 Oct; 234(4773):151-2. PubMed ID: 3018927
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical aspects of feline retroviruses: a review.
    Hartmann K
    Viruses; 2012 Oct; 4(11):2684-710. PubMed ID: 23202500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical aspects of feline immunodeficiency and feline leukemia virus infection.
    Hartmann K
    Vet Immunol Immunopathol; 2011 Oct; 143(3-4):190-201. PubMed ID: 21807418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockout of caspase-like gene, YCA1, abrogates apoptosis and elevates oxidized proteins in Saccharomyces cerevisiae.
    Khan MA; Chock PB; Stadtman ER
    Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17326-31. PubMed ID: 16301538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feline ubiquitin fusion protein genes.
    Kano R; Kubota A; Nakamura Y; Watanabe S; Hasegawa A
    Vet Res Commun; 2001 Dec; 25(8):615-22. PubMed ID: 11767007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the ubiquitin-proteasome pathway in apoptosis.
    Orlowski RZ
    Cell Death Differ; 1999 Apr; 6(4):303-13. PubMed ID: 10381632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging.
    Dardevet D; Sornet C; Taillandier D; Savary I; Attaix D; Grizard J
    J Clin Invest; 1995 Nov; 96(5):2113-9. PubMed ID: 7593595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ubiquitin-proteasome pathway: on protein death and cell life.
    Ciechanover A
    EMBO J; 1998 Dec; 17(24):7151-60. PubMed ID: 9857172
    [No Abstract]   [Full Text] [Related]  

  • 37. The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes.
    Liu Z; Miers WR; Wei L; Barrett EJ
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1255-60. PubMed ID: 11027619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells.
    Fukazawa T; Fujiwara T; Uno F; Teraishi F; Kadowaki Y; Itoshima T; Takata Y; Kagawa S; Roth JA; Tschopp J; Tanaka N
    Oncogene; 2001 Aug; 20(37):5225-31. PubMed ID: 11526513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein degradation and apoptotic death in lymphocytes during Fiv infection: activation of the ubiquitin-proteasome proteolytic system.
    Piedimonte G; Crinelli R; Della Salda L; Corsi D; Pennisi MG; Kramer L; Casabianca A; Sarli G; Bendinelli M; Marcato PS; Magnani M
    Exp Cell Res; 1999 May; 248(2):381-90. PubMed ID: 10222130
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.